title: Recent advances in hepatic transplantation at the University of Pittsburgh.
abstract: FK506 undoubtedly improved the survival advantage of hepatic allotransplantation. Hepatic-intestinal and multivisceral transplantation has also become a feasible therapy for patients with combined intestinal and liver failure. With better understanding of the immunologic and metabolic aspects of allo- and xenotransplantation, further clinical attempts to transplant animal organs to humans may be considered with the hope for a better outcome in the very near future.
authors.affiliation: University of Pittsburgh Medical Center, Pittsburgh Transplant Institute, Pennsylvania.
authors.forename: K
authors.initials: K
authors.lastname: Abu-Elmagd
authors.forename: O
authors.initials: O
authors.lastname: Bronsther
authors.forename: A
authors.initials: A
authors.lastname: Jain
authors.forename: W
authors.initials: W
authors.lastname: Irish
authors.forename: H
authors.initials: H
authors.lastname: Ramos
authors.forename: I R
authors.initials: IR
authors.lastname: Marino
authors.forename: F
authors.initials: F
authors.lastname: Dodson
authors.forename: R
authors.initials: R
authors.lastname: Selby
authors.forename: H
authors.initials: H
authors.lastname: Doyle
authors.forename: H
authors.initials: H
authors.lastname: Furukawa
mesh_terms: D000046:Academic Medical Centers; D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D005260:Female; D006085:Graft Survival; D006801:Humans; D007422:Intestines / Q000637:transplantation; D008107:Liver Diseases / Q000401:mortality / Q000601:surgery; D016031:Liver Transplantation / Q000276:immunology / Q000379:methods* / Q000706:statistics & numerical data; D008297:Male; D008875:Middle Aged; D010215:Papio; D010414:Pennsylvania; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D016559:Tacrolimus / Q000627:therapeutic use; D014183:Transplantation, Heterologous
chemical_list: D016559:Tacrolimus